Efficacy and safety of definitive chemoradiotherapy with or without induction immune checkpoint inhibitors in patients with stage III non-small cell lung cancer

Efficacy and safety of definitive chemoradiotherapy with or without induction immune checkpoint inhibitors in patients with stage III non-small cell lung cancer

BackgroundIn the era of immunotherapy, the optimal combination of immune checkpoint inhibitors (ICIs) and chemoradiotherapy (CRT) for stage III non-small cell lung cancer (NSCLC) is not defined. The current study investigated the efficacy and safety of definitive CRT(dCRT) plus consolidation ICIs wi...

Full description

Bibliographic Details
Main Authors: Yin Yang, Jianyang Wang, Tao Zhang, Zongmei Zhou, Yu Wang, Ying Jiang, Wenyang Liu, Zefen Xiao, Lei Deng, Qinfu Feng, Xin Wang, Jima Lv, Wenqing Wang, Qi Xue, Jie Wang, Ye-Xiong Li, Nan Bi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Immunology
Subjects:
stage III non-small cell lung cancer
chemoradiotherapy
immune checkpoint inhibitors
efficacy
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1281888/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1281888/full

Similar Items